DAWN

7.47

3.98% -0.31

Dopo l'orario di chiusura: 7.47

Day One Biopharmaceuticals Inc (DAWN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$7.78

Aprire:

$7.85

Volume 24 ore:

1.49M

Relative Volume:

0.98

Capitalizzazione di mercato:

$765.17M

Reddito:

$187.64M

Utile/perdita netta:

$-95.00M

Rapporto P/E:

-7.8632

EPS:

-0.95

Flusso di cassa netto:

$-69.02M

1 W Prestazione:

+0.40%

1M Prestazione:

+5.06%

6M Prestazione:

+10.50%

1 anno Prestazione:

-50.23%

Intervallo 1D:

$7.375

$8.10

Intervallo di 1 settimana:

$6.98

$8.10

Portata 52W:

$5.635

$16.76

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Nome

Day One Biopharmaceuticals Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

650 484-0899

Indirizzo

2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE

Dipendente

181

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

DAWN's Discussions on Twitter

Confronta DAWN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DAWN Day One Biopharmaceuticals Inc	7.47	722.15M	187.64M	-95.00M	-69.02M	-0.95
VRTX Vertex Pharmaceuticals Inc	408.61	105.69B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.07	61.52B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	569.17	60.69B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	837.28	50.05B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	318.02	35.25B	4.56B	-176.77M	225.30M	-1.7177

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-19	Iniziato	Piper Sandler	Overweight
2024-10-09	Reiterato	Needham	Buy
2024-08-01	Aggiornamento	BofA Securities	Underperform → Buy
2024-04-24	Reiterato	Needham	Buy
2023-04-25	Downgrade	BofA Securities	Buy → Underperform
2023-02-08	Iniziato	CapitalOne	Overweight
2023-02-03	Iniziato	Oppenheimer	Perform
2022-12-15	Iniziato	H.C. Wainwright	Buy
2022-12-14	Iniziato	Needham	Buy
2022-12-05	Iniziato	Goldman	Buy
2022-12-01	Iniziato	BofA Securities	Buy

Mostra tutto

Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie

Oct 16, 2025

Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockTrend Reversal & AI Enhanced Execution Alerts - newser.com

Oct 16, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Upgraded at Zacks Research - Defense World

Oct 16, 2025

Oct 15, 2025

Is Day One Biopharmaceuticals Inc. stock oversold or undervaluedJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com

Oct 15, 2025

How Day One Biopharmaceuticals Inc. stock benefits from global expansion2025 Trading Recap & Real-Time Chart Breakout Alerts - newser.com

Oct 15, 2025

Oct 14, 2025

Signal strength of Day One Biopharmaceuticals Inc. stock in tech scannersTrade Performance Summary & Consistent Income Trade Ideas - newser.com

Oct 14, 2025

Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet - Yahoo Finance

Oct 14, 2025

Can Day One Biopharmaceuticals Inc. rally from current levelsQuarterly Market Review & Consistent Profit Trading Strategies - newser.com

Oct 14, 2025

Oct 13, 2025

Detecting support and resistance levels for Day One Biopharmaceuticals Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com

Oct 13, 2025

What does recent volatility data suggest for Day One Biopharmaceuticals Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com

Oct 13, 2025

Statistical indicators supporting Day One Biopharmaceuticals Inc.’s strength2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com

Oct 13, 2025

Top chart patterns to watch in Day One Biopharmaceuticals Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 13, 2025

Automated trading signals detected on Day One Biopharmaceuticals Inc. - newser.com

Oct 13, 2025

Oct 11, 2025